Skip to main content

日复一日,我们努力工作以对环境产生积极影响。

在药品的生产和销售方面,环境可持续性已不再被简单地视为核心业务实践的补充。在Centrient Pharmaceuticals,我们相信保护环境是像我们这样的公司前进的唯一途径。

在全球范围内,可以通过新的环境标准和措施来对我们行业进行越来越严格的审查。以中国为例,其``蓝天''行动计划旨在通过最大程度地减少化学和制药行业公司的影响来增加清洁空气日数。

从更广泛的角度来看,对环境可持续性的不断增长的需求不仅影响制药公司本身,还影响其供应链和采购实践。许多国家正在将具体标准引入其招标程序,以提高供应商标准。

我们的目标不仅仅是满足我们运营所在的不同地区和辖区的环境要求。我们旨在通过为我们的供应商和合作伙伴树立榜样,在药品供应链中引领环境可持续发展。因为我们可以一起做出真正的改变。

When it comes to making and selling pharmaceuticals, environmental sustainability can no longer be viewed simply as an add-on to core business practices. At Centrient Pharmaceuticals, we believe safeguarding the environment is the only way forward for companies like ours.

Around the world, the increased scrutiny on our industry can be seen in new environmental standards and initiatives. Take China, whose 'blue-sky' action plan aims to increase the number of clean air days by minimising the impact of companies working in the chemical and pharmaceutical industry.

More widely, growing demand for environmental sustainability not only affects pharmaceutical companies themselves, but also their supply chains and procurement practices. A number of countries are introducing specific criteria into their tender processes with a view to raising supplier standards.

Our goal is not simply to meet the environmental demands of the different regions and jurisdictions where we operate. We aim to lead the way in environmental sustainability within the pharmaceutical supply chain by setting a strong example for our suppliers and partners. Because together we can make a real difference.

可持续采购:对我们的供应商和制造合作伙伴的评估

作为我们负责任的采购方法的一部分,环境绩效和合规性是选择主要原材料供应商和合同制造组织的重要标准。

供应商由PSCI批准的审计公司和内部评估进行评估。评估基于PSCI自我评估问卷(SAQ)。它涵盖了劳动和人权,道德,健康与安全,环境和管理系统等领域。

我们的供应商签署了Centrient Pharmaceuticals的《商业行为准则》,其中包括对环境绩效,人权,道德和其他关键主题的要求。

与我们负责任地和可持续地生产抗生素的努力相一致,我们评估了我们的供应商和我们与废物排放实践合作的其他第三方。我们内部开发的在线AMR调查有助于提高透明度,并确定与供应商进行负责任的抗生素生产的进一步改进的领域。

Sustainable procurement: assessment of our suppliers and manufacturing partners

As part of our responsible procurement approach, environmental performance and compliance are important criteria for the selection of our key raw material suppliers and Contract Manufacturing Organisations.

Suppliers are assessed by PSCI-approved audit firms and in-house assessments. The assessments are based on the PSCI Self-Assessment Questionnaire (SAQ). It covers areas such as labour and human rights, ethics, health and safety, environment and management systems.

Our suppliers sign the Centrient Pharmaceuticals’ Business Code of Conduct, which includes requirements on environmental performance, human rights, ethics and other key topics.

In line with our efforts to produce antibiotics responsibly and sustainably, we assess our suppliers and other third parties we work with on waste discharge practices. Our in-house developed online AMR survey helps to increase transparency and identify areas for further improvement towards responsible antibiotics production with our suppliers.